• Report Provides Information on 33 New Humira Biosimilar Therapy Candidates for RA
  • Specific Fibroblasts Found to Promote Joint Damage in RA, Study Shows
  • Children Born to Moms with Rheumatoid Arthritis at Risk for Epilepsy, Study Finds
  • Genalyte’s Diagnostic Tool Shows Potential to Improve Turnaround Time in RA, Other Conditions
  • Chronic Inflammation May Explain Heart Disease in Rheumatoid Arthritis
  • Researchers Will Use Real-Life Experiences to Gauge Impact of RA-Specific Drug Therapies
  • Clinical Data Support Phase 3 Trials of Olokizumab for Rheumatoid Arthritis, R-Pharm Reports
  • Therapy for Autoimmune Diseases Like RA Shows Positive Results in Clinical Trial
  • Fewer RA Patients Who Took Remicade Quit Treatment Than Those Who Used Biosimilar CT-P13
  • Certain Rheumatoid Arthritis Patients Improved Faster with Baricitinib than Humira, Studies Show
  • Baricitinib’s Effectiveness in Treating RA Symptoms Supported in New Analyses of Phase 3 Trials
  • Pfizer Presents New Positive Results on Xeljanz for Rheumatoid Arthritis